2.737ng·É»ú¹²ÓÐ5¿îacpÃæ°å,·ÖΪÁ½´óÀà,Ö÷񻂿±ðÊÇ? - °Ù¶È...

737NG·É»ú5¿îACPÃæ°åµÄÁ½´óÀàÖ÷񻂿±ðÊÇ£ºÒ»¿îµÄPTTµçÃÅ×Ô¶¯»ØÖÐÁ¢Î»£¬ÁíÒ»¿îËø¶¨ÔÚÎÞÏߵ緢Éäλ¡£ÒÔÏÂÊǹØÓÚÕâÁ½ÀàACPÃæ°åµÄÏêϸ½âÊÍ£ºÒ»¡¢PTTµçÃÅ×Ô¶¯»ØÖÐÁ¢Î»µÄACPÃæ...

Ö§¸¶±¦ÂôµÄÌ©¿µÀÖÔöÊÙ,ÐÔ¼Û±ÈÔõôÑù?

ÓëÊÕÒæ×î¸ßµÄºã´óÍòÄêìû¶Ô±È£¬50Íò±¾½ðÏÂÊÕÒæ²î´ï203231Ôª¡£IRRÊÕÒæÂʵͣºõ»½»µÚ30ÄêIRRΪ2.96%£»·Ö3Ä꽻Ϊ2.87%£»·Ö5Ä꽻Ϊ2.867%£»·Ö10Äê...

Å©·òɽȪËÕ´òÆøÅÝˮΪʲôûÓÐÄÆ?

Ò»¡¢ÄÆÔÚСËÕ´òÖеĺ¬Á¿ СËÕ´ò£¬Ò²³ÆÎªÌ¼ËáÇâÄÆ£¬Æä·Ö×ÓʽΪ NaHCO 3¡£ÎªÁ˼ÆËãÄÆ£¨Na£©ÔÚСËÕ´òÖеıÈÀý£¬ÎÒÃÇÐèÒªÖªµÀÿ¸öÔªËØÔÚ·Ö×Ó...

Õã½­»ªÔ¶ÄæÊƳå´ÌÉÏÊÐ,¸ÃÆóҵδÀ´·¢Õ¹Ç°¾°ÈçºÎ?

¹«Ë¾´Ó2022Äê~2024Äê¼ä£¬ÓªÊÕ·Ö±ðÊÇ4.912ÒÚ¡¢5.533ÒÚ£¬6.817ÒÚ£¬2024ÄêµÄÓªÊÕͬ±ÈÔö³¤23.2%£»¾»ÀûÈó·Ö±ðÊÇ7682Íò¡¢8264Íò¡¢1.077ÒÚ£¬2024...

ÈçºÎ¼ÆËã¸Ö¹Ü±Úºñ

63.5 1.84 2.14 2.29 2.44 2.74 3.03 3.33 3.76 4.19 4.48 4.76 5.18 65 2.35 2.50 2.81 3.11 3.41 3.85 4.29 4.59 4.88 5.31 70...

¹úºèÇâÄÜÉÏÊÐÊ×ÈÕÅÌÖÐϵø25%,3Äê¿÷Ëð½ü12ÒÚ,Ôø»ñÃÀ½õÄÜ ...

Ò»¡¢ÉÏÊÐÊ×Èչɼ۱íÏÖ·¢ÐÐÓ뿪ÅÌÇé¿ö£º¹úºèÇâÄܿƼ¼£¨¼ÎÐË£©¹É·ÝÓÐÏÞ¹«Ë¾ÓÚ12ÔÂ5ÈÕÕýʽµÇ½¸Û½»Ëù£¬·¢ÐмÛΪ19.66¸ÛÔª/¹É£¬¾»³ïÔ¼14.56ÒÚ...

ÖйúÒøÐÐÅÅÃû,Öйú¸÷´óÒøÐÐÅÅÃûÒ»ÀÀ

9¡¢ÉϺ£ÆÖ¶«·¢Õ¹ÒøÐÐ:ºËÐÄÒ»¼¶×ʱ¾¾»¶î5.192.68ÒÚ£¬×ʲú¹æÄ£79.502.18ÒÚ£¬¾»ÀûÈó589.93ÒÚ£¬³É±¾ÊÕÈë±È23.78%£¬²»Á¼´û¿îÂÊ1.73%¡££»10¡¢ÖÐÐÅÒøÐÐ:ºËÐÄÒ»¼¶×ʱ¾¾»¶î4...

ÍõÀö¾©ÈËÎï½éÉÜ

Liu,Pei-QingLiu,He-QingHuang.TanshinoneIIAattenuatesatherosclerosisinApoE_/_micethroughdown-regulationofscavengerreceptorexpression.EuropeanJournalofPharmacology2011,275-284(IF:2.737)...

ÌúµÄÍ¬Î»ËØÓм¸¸ö,·Ö±ðÊÇʲô? ллÁË!

ÓÐÇÒÖ»ÓÐ3ÖÐ Ìú54 Ìú56 Ìú57 ÔÂÇòÌú57¶ÔÌú54µÄ±ÈÀýÒª±ÈµØÇò¸ßÒ»µã¡£ ÆäʵÒÔÏÖÔڵĿƼ¼Ë®Æ½»¹¿ÉÒÔÈ˹¤ºÏ³ÉÌúµÄÆäËüÍ¬Î»ËØ¡£·ûºÅ

ÖÜÌ컪µÄ·¢±íÖ÷ҪԭʼÂÛÎÄ

×÷ΪͨѶ×÷Õߺ͵ÚÒ»×÷ÕßµÄÖ÷ÒªÂÛÎÄ£¨* ͨѶ×÷Õߣ©£º1. Xu Y, Deng Y, Yan X and Zhou T*. Targeting miR-375 in gastric cancer. ...

Ïà¹ØËÑË÷